CopyMark Law Group
4.9/5
Drawing for BIOLUMI

USPTO serial 79177788

BIOLUMI

Reviewed by CopyMark Law Group

Reg. 5047458Status 706Renewal
Filing date
Status date
Registration date
Sep 27, 2016
Examiner
SEVERSON, KAREN
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with BIOLUMI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $850

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stacy L. Emhoff

Stacy L. Emhoff Walker & Jocke Co., LPA231 South BroadwayMedina, OH 44256United States

Goods and services

ClassDescriptionStatusFirst use
005[ Drugs for medical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin disease; chemical preparations for the diagnosis of pregnancy; Medicated serums for invitro diagnosis of pregnancy and treatment of blood conditions during pregnancy; Serotherapeutic medicines for the treatment of hepatitis; cultures of microorganisms for medical and veterinary use; biological preparations for pharmaceutical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; Chemical preparations for pharmaceutical purposes, namely, for diagnosis or treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; Diagnostic preparations for medical purposes, namely, for diagnosing or detecting tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; enzymes for medical purposes; enzyme preparations for medical purposes ]SECTION 71 - CANCELLED—
010Blood testing apparatus; [ massage apparatus; ] Testing apparatus for medical purposes, namely, medical testing instrument for testing blood samples, body fluids and body tissue samples; Apparatus for use in medical analysis, namely, medical analyzer for analysis of blood samples, body fluids and body tissue samples; Diagnostic apparatus for medical purposes, namely, medical diagnostic analyzer for analyzing blood samples, body fluids and body tissue samples [ ; radiotherapy apparatus; Ultrasonic devices for medical use, namely, clinical ultrasonic diagnostic apparatus; artificial limbs; Multifunction corsets for medical purpose, namely, diagnosis and therapeutic corsets for medical purpose; suture materials ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 16, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 16, 202671AGREGISTERED-SEC.71 ACCEPTED—
Sep 8, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 16, 2026ES71TEAS SECTION 71 RECEIVED—
Apr 2, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 27, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jul 10, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Apr 18, 2023INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Mar 13, 2023XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Mar 13, 2023XXCRGENERIC MADRID TRANSACTION CREATED—
Jan 19, 2023INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 19, 2022NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 19, 202271.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
May 10, 2022EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Apr 30, 2022PR71POST REGISTRATION ACTION MAILED - SEC.71—
Apr 27, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 27, 2021ES71TEAS SECTION 71 RECEIVED—
Feb 20, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 23, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 29, 2016XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Dec 29, 2016XXCRGENERIC MADRID TRANSACTION CREATED—
Dec 27, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 27, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 15, 2016OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 12, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 22, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 22, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 22, 2016NPUBNOTICE OF PUBLICATION—
Jun 9, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 2, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 1, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 1, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 1, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 27, 2016CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 27, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 25, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 25, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 22, 2016ALIEASSIGNED TO LIE—
Jan 10, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 10, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 5, 2016RFNTREFUSAL PROCESSED BY IB—
Dec 16, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 16, 2015RFRRREFUSAL PROCESSED BY MPU—
Dec 15, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 15, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 14, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 11, 2015DOCKASSIGNED TO EXAMINER—
Dec 11, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 10, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance